نتایج جستجو برای: lamotrigine monotherapy

تعداد نتایج: 16820  

2016
Kexin Wang Alejandro Fernandez-Escobar Shuhong Han Ping Zhu Jun-Hui Wang Yu Sun

Alzheimer's disease (AD) has been described in the literature, to be associated with impairment of executive function which develops early in the course of disease, and an effective treatment for this clinical feature remains elusive. Preclinical studies have implied that lamotrigine, an antiepileptic agent, could be a potential treatment for executive dysfunction in AD patients. Although there...

Journal: :iranian journal of child neurology 0
parvaneh karimzadeh associate professor of pediatric neurology, shahid beheshti university of medical sciences(sbmu), pediatric neurology research center, tehran, iran

objective neurodevelopmental disability is one of the most common problems of children referred to  pediatric neurology clinics. these children may suffer from speech delay, intellectual deficiency and behavioral disorder. some patients with neurodevelopomental delay, especially those with intellectual disability and speech problems, have abnormal electroencephalograms, without clinical seizure...

Journal: :Pharmacology Biochemistry and Behavior 2012
Helena M. Abelaira Gislaine Z. Réus Karine F. Ribeiro Giovanni Zappellini Andreza L. Cipriano Giselli Scaini Emilio L. Streck João Quevedo

Lamotrigine is an anticonvulsant and has an antiglutamatergic action, which may contribute to its antidepressant effects, since glutamate has been linked to depression. The purpose of the present study was to investigate the behavioral and molecular effects of lamotrigine treatment in maternally deprived rats. To this aim, deprived and non-deprived male rats were treated with lamotrigine (20 mg...

Journal: :Journal of Clinical Neurology (Seoul, Korea) 2007
Dong-Gun Kim Seung-Hun Oh Ok Joon Kim

A wide variety of movement disorders can be induced by the administration of antiepileptic drugs. A 44-year-old female was admitted with involuntary excessive eye blinking that manifested 5 months after beginning the administration of lamotrigine for control of complex partial and secondarily generalized seizures. The involuntary eye blinking persisted while taking lamotrigine, and disappeared ...

2016
Unshik Ha Myung Hun Jung Narei Hong

A 55-year-old female with no physical problems was initially hospitalized for psychotic mania but soon discharged. A month later she was rehospitalized for bipolar depression and treated with lamotrigine (25 mg/day), olanzapine (10 mg/day), and lorazepam (0.5 mg/day). On day 22, lamotrigine was stopped because of neutropenia. On the same day, the patient developed skin rashes with pruritus, whi...

2015
Derek K. Tracy Dan W. Joyce S. Neil Sarkar Maria-Jesus Mateos Fernandez Sukhwinder S. Shergill

BACKGROUND Clozapine is the treatment of choice for medication refractory psychosis, but it does not benefit half of those put on it. There are numerous studies of potential post-clozapine strategies, but little data to guide the order of such treatment in this common clinical challenge. We describe a naturalistic observational study in 153 patients treated by a specialist psychosis service to ...

2013
Shama Parveen M. Afzal Javed

Stevens-Johnsons Syndrome (SJS) is an immune-complex-mediated hypersensitivity reaction and has been linked as an adverse side effects to many drugs. Lamotrigine, an anticonvulsive medication and also a commonly used mood stabiliser, can be associated with this adverse reaction. Although this has not been reported very commonly , SJS has high mortality and morbidity and requires careful attenti...

Journal: :International healthcare research journal 2022

Lamotrigine is an antiepileptic drug widely used to control seizures. It has many adverse events but in rare instances, it can cause hypersensitivity syndrome (DHS). We describe a case of lamotrigine induced characterized by febrile erythema and eosinophilia. The suspect was replaced valproate leading marked improvement.

2017
Neil Brickel Haris Shaikh Andrew Kirkham Greg Davies Michelle Chalker Pascal Yoshida

Pharmacovigilance presents many challenges, particularly when managing unpredictable, rare conditions, eg, severe cutaneous adverse reactions (SCARs). Such rare events are often only detected from spontaneous reports, which present their own limitations, particularly during a prolonged global launch schedule. GlaxoSmithKline's routine pharmacovigilance includes regular reviews of global adverse...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید